Delivery Order SPE2DB20D3103-SPE2DB25FP9W2
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $1,136.93 to AmerisourceBergen Drug Corp for the supply of Doxycycline Monohydrate 100 mg capsules in unit-dose packaging of 30 tablets. This is a firm fixed-price delivery order with no set-aside designation, competitively awarded and completed on July 24, 2025. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as the place of performance for this pharmaceutical supply arrangement. This delivery order is issued...
- The Defense Logistics Agency awarded a delivery order valued at $10,374.00 to AmerisourceBergen Drug Corp for the supply of Doxycycline Hyclate 100 mg tablets (300 count) on August 21, 2025, with an ultimate completion date of August 22, 2025. This competitively awarded contract utilizes firm fixed pricing with no set-aside designation. The pharmaceutical product will be delivered to the contractor's facility in Conshohocken, Pennsylvania, where the company maintains its corporate office. This...
- The Defense Department's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on July 22, 2025, for the supply of Doxycycline Hyclate 100 mg tablets in quantities of 500 units, with a contract ceiling value of $2,077.68. This is a firm fixed-price delivery order with an ultimate completion date of July 23, 2025, and represents a non-set-aside competitive award. The place of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its...
- The Defense Logistics Agency awarded a $20,468.22 delivery order to AmerisourceBergen Drug Corp for 60-tablet units of Doxycycline 50 mg on July 29, 2025, with an ultimate completion date of July 30, 2025. This non-set-aside, competitively awarded contract utilizes firm fixed pricing and represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The place of performance is...
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 18, 2025, for the supply of Doxycycline Hyclate, an antibiotic medication. This firm fixed-price delivery order, valued at $4,243.50, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), which is valued at $999.999 billion and extends through December 2026. The delivery order carries no...
- The U.S. Defense Department's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Doxycycline Hyclate 100 mg tablets in quantities of 1,000 units at a firm fixed price ceiling value of $2,952.00. This contract, awarded on August 4, 2025, with an ultimate completion date of August 5, 2025, represents a non-set-aside competitive award. The place of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $2,091.90 on July 22, 2025, for the supply of Doxycycline Hyclate 100 mg tablets in unit-dose packaging (50-count). This firm fixed-price, competitively awarded contract was funded by the Defense Logistics Agency's Medical Supply Chain and is scheduled for ultimate completion by July 23, 2025. The award carries no set-aside designation, reflecting...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $6,232.51 for Doxycycline 50 mg tablets (60-count units) on August 21, 2025, with completion scheduled for August 22, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The award represents a small-value transaction within AmerisourceBergen's broader...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $6,099.86 to AmerisourceBergen Drug Corp for the supply of Doxycycline 50 mg tablets (60-count packages) with an ultimate completion date of July 30, 2025. This is a firm fixed-price delivery order with no set-aside designation, indicating competitive award. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's...
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on July 23, 2025, for the supply of Doxycycline Hyclate 100 mg tablets in quantities of 1,000 units. This competitively awarded, non-set-aside contract carries a ceiling value of $2,460.00 with firm fixed pricing and an ultimate completion date of July 24, 2025. The pharmaceutical products will be performed and delivered from the contractor's corporate office location in Conshohocken,...
- SPE2DB20D3103Indefinite Delivery Contract
- SPE2DB20D3103-SPE2DB25FP9W2Delivery Order
The Defense Logistics Agency awarded a delivery order valued at $6,895.70 to AmerisourceBergen Drug Corp for the supply of Doxycycline Monohydrate 100 mg capsules (250-count) on August 22, 2025, with an ultimate completion date of August 25, 2025. This is a firm fixed price delivery order with no set-aside designation, indicating it was competitively awarded. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This contract represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which carries a ceiling value of $999,999,999.00 and extends through December 2026. AmerisourceBergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider serving as a critical federal medical procurement vendor, particularly for military and veteran healthcare systems. The parent IDC vehicle enables the company to supply a comprehensive range of pharmaceutical products and medical supplies, including brand-name and generic medications, vaccines, and specialized medical devices across multiple therapeutic domains to support Defense Health Agency, U.S. Coast Guard, and other government healthcare systems globally. The DLA Troop Support is planning to establish next-generation Pharmaceutical Prime Vendor Global Program contracts with multiple regional awards, positioning AmerisourceBergen competitively for continued federal medical supply delivery.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $6.9k | 8/22/25 |